Loading events...
Volv Global CEO and Founder Christopher Rudolf will speak on optimising rare disease clinical trials with Real World Data at the Rare Trials Summit 2025 in Boston in September. The development of inclusion/exclusion criteria for clinical trial protocols can make or break drug development. Can we expand medical knowledge and discover new phenotypes and biomarkers for diseases – enabling precision targeting of the right patients for recruitment – by using data-driven machine learning methodologies
Tuesday, September 9, 2025 - Wednesday, September 10, 2025
Boston, USA
Volv Global CEO and Founder Christopher Rudolf will speak on optimising rare disease clinical trials with Real World Data at the Rare Trials Summit 2025 in Boston in September. The development of inclusion/exclusion criteria for clinical trial protocols can make or break drug development. Can we expand medical knowledge and discover new phenotypes and biomarkers for diseases – enabling precision targeting of the right patients for recruitment – by using data-driven machine learning methodologies
Receive curated event recommendations based on your interests.
See how WebMobi helps you manage registration, check-in, and analytics.
Request a DemoOr start free trial →Optimising Rare Disease Clinical Trials with Real World Data Using NLP & AI takes place on Tuesday, September 9, 2025 to Wednesday, September 10, 2025.
Optimising Rare Disease Clinical Trials with Real World Data Using NLP & AI is held in Boston, USA at Sheraton Boston Hotel.
Pricing information is available on the event website.
Optimising Rare Disease Clinical Trials with Real World Data Using NLP & AI is designed for technology professionals looking to network, learn, and discover new opportunities.
Get curated B2B events, AI-powered insights, and industry trends delivered to your inbox